Huons Group affiliate Huons Meditec is moving to solidify its position in the aesthetic market based on the expansion of its aesthetic lineup and academic marketing targeting medical professionals. With a multilayered portfolio spanning cosmetics, prescription drugs, and medical devices, the company aims to grow into a total aesthetic specialist.

In November 2024, Huons Meditec introduced domestic dermatology and aesthetic clinic distribution rights for “Elravie Lituo” in partnership with L&C Bio. Buoyed by the sales growth of Elravie Lituo, the company diversified its aesthetic product portfolio through in-house development and distribution agreements.

Huons Meditec opened its skin booster line with “Elravie Lituo,” an extracellular matrix (ECM) booster that applies, for the first time in Korea, human-derived acellular dermal matrix (hADM). Backed by sales growth centered on dermatology clinics, the company introduced next-generation products by securing their distribution rights.

Esthfill, a PDLLA (Poly D, L-lactide) filler, has further expanded the skin booster portfolio as Huons Meditec secured its official domestic distribution rights. The globally rebranded Esthfill products were subsequently unveiled this January at the “World Congress 2026” of the International Master Course on Aging Science (IMCAS) held in Paris, France.

The company is also focusing on research and development to discover next-generation products. To address a wide range of indications, it is developing filler products that combine collagen, polynucleotide sodium (PN), and polylactic acid (PLA). In December last year, it completed clinical trials for “Belpien,” a PN-hyaluronic acid (HA) complex filler, and is preparing to obtain product approval in the first half of this year.

Riddle Booster, Olifit… expanding the portfolio and academic marketing

As competition in the domestic aesthetic procedure market intensifies, Huons Meditec is building a portfolio to target the aesthetic segment through products it manufactures itself and those for which it holds distribution rights. In August last year, it successively launched the topical skin booster “Riddle Booster PN/EX,” the submental fat improvement injectable “Olifit,” and the next-generation wound dressing “Arche,” thereby expanding its lineup.

Huons Meditec recently successfully concluded the second “HART Symposium,” an academic event focused on aesthetic medicine. The company invited 150 medical experts to the symposium and presented academic evidence and treatment cases related to its key aesthetic products. Through various online and offline academies and academic events that highlight the latest insights in aesthetic medicine for healthcare professionals, Huons Meditec is concentrating on raising awareness of its core product groups.

Elravie fillers, medical devices, and Liztox as a total solution

Huons Meditec has established its presence in the aesthetic market through “Elravie” fillers, launched in 2012. In the domestic aesthetic market, it secures a competitive edge by cross-selling Elravie fillers, medical devices, and the botulinum toxin “Liztox.”

Its filler products include Elravie Premier and Rebol Line. Elravie Premier is categorized into Balance, Soft, Light-L, Deep Line-L, and Ultra Volume-L according to HA (hyaluronic acid) content and rheological properties. A Plus line is also available. Recently, “Elravie Deep Line-L” obtained additional registration with the NMPA (National Medical Products Administration) in China, and “Elravie Deep Line Plus,” “Elravie Ultra Volume Plus,” and “Elravie Light Plus” acquired official product approvals in Syria. Huons Meditec is expanding its global market presence by diversifying its export destinations.

Huons Meditec also cross-sells “Dermashine Duo RF,” a medical device from its group affiliate Huons Meditech. This is an innovative aesthetic medical device that combines precise drug injection with radiofrequency (RF) lifting functionality. It is optimized for injecting high-viscosity polymer skin booster formulations such as poly-L-lactic acid (PLLA), poly-D-lactic acid (PDLA), and polycaprolactone (PCL).

Expanding consumer touchpoints with “Elravie Cosmetic”

Huons Meditec has expanded consumer touchpoints through direct-to-consumer (D2C) sales of “Elravie Cosmetic,” its cosmetics brand for the general public. Recently, six products from the Elravie Cosmetic “Hycica Mu” brand were launched on Amazon in the United States. Domestically, Huons Meditec’s Elravie Cosmetic has built brand recognition through its own online mall and TV home shopping programs such as Lotte Homeshopping’s “Choi Yoo-ra Show.” Following the Hycica Mu brand, the company plans to sequentially roll out various Elravie Cosmetic brands on Amazon, including “Atoferon,” “Elravie Zero,” and “Elravie Pro.”

Popular News